Report : A-Z HCD items in Formulary 13/04/2021 13:31:51
[
Back
]
Section
Status
CCG
Name
01.05.03
Formulary
Adalimumab Amgevita
10.01.03
Formulary
Adalimumab Amgevita
13.05.03
Formulary
Adalimumab Amgevita
13.05.03
Formulary
Adalimumab Amgevita
13.05.03
Formulary
Brodalumab Kyntheum
13.05.03
Formulary
Certolizumab Cimzia
13.05.03
Formulary
Dimethyl fumarate Skilarence
13.05.03
Formulary
Dupilumab Dupixent
®
04.07.04.02
Restricted Use
Erenumab
13.05.03
Formulary
Etanercept Benepali
04.07.04.02
Formulary
Fremanezumab Ajovy
04.07.04.02
Formulary
Galcanezumab Emgality
01.05.03
Formulary
Golimumab Simponi
®
13.05.03
Formulary
Golimumab Simponi
13.05.03
Formulary
Guselkumab Tremfya
01.05.03
Formulary
Infliximab Remsima
13.05.03
Formulary
Infliximab Remsima
13.05.03
Formulary
Ixekizumab Taltz
®
13.05.03
Formulary
Omalizumab Xolair
13.05.03
Formulary
Risankizumab Skyrizi
13.05.03
Formulary
Secukinumab Cosentyx
®
13.05.03
Formulary
Tildrakizumab Ilumetri
01.05.03
Formulary
Tofacitinib Xeljanz
13.05.03
Formulary
Tofacitinib Xeljanz
10.01.03
Formulary
Upadacitinib Rinvoq
01.05.03
Formulary
Ustekinumab Stelara
®
13.05.03
Restricted Use
Ustekinumab Stelara
01.05.03
Formulary
Vedolizumab Entyvio
®
Bradford Teaching Hospitals